Fiche centre
Henri Mondor Hospital
Créteil — France
Essais liés2clinical trials
VilleCréteillocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06152575
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Elranatamab | Cancer | Phase 3 | NCT06152575 | MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) | RECRUITING |
| AEROPROTECT — Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease | Parkinson | Non applicable | NCT04046276 | AEROPROTECT — Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease | UNKNOWN |